NCT00156195View on ClinicalTrials.gov

Study to Evaluate the Safety of Asoprisnil in the Treatment of Uterine Fibroids

PHASE3CompletedINTERVENTIONAL
Enrollment

523

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

January 31, 2007

Study Completion Date

January 31, 2007

Conditions
LeiomyomaMenorrhagiaMetrorrhagia
Interventions
DRUG

Asoprisnil

10 mg Tablet, oral Daily for 12 months

DRUG

Asoprisnil

25 mg Tablet, oral Daily for 12 months

Sponsors

Lead Sponsor

Abbott
All Listed Sponsors
lead

Abbott

INDUSTRY